<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02406937</url>
  </required_header>
  <id_info>
    <org_study_id>14-SC-9-FH-001</org_study_id>
    <nct_id>NCT02406937</nct_id>
  </id_info>
  <brief_title>New Stage 1 Formula on Gut Comfort and Gut Health</brief_title>
  <official_title>Efficacy of New Stage 1 Formula on the Improvement of Gut Comfort and Gut Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heilongjiang Feihe Dairy Co. Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heilongjiang Feihe Dairy Co. Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      180 qualified subjects aged from 7 days to 90 days will be enrolled with the 144 completed in
      study (allowing for a 20% drop-out rate). Subjects will be randomly assigned into 3 groups,
      including breast feeding, commercial and new formula group. Study intervention is 12 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary objective:

      1. Improvement on gut health and infant comfort

      Secondary objectiveï¼š

        1. Efficacy on easy digestion;

        2. Changes on SCFA in feces(Baseline and Endpoint)

        3. Improvement on gut microbiome strains(Baseline and Day 21);
           (bifidobacterium/lactobacillus/clostridium perfringens recommended)

        4. Changes on sIgA in feces(Baseline and Endpoint)

        5. Improvement on tolerance(comfort) via infant fussy/bloating/abdominal pain/milk
           regurgitation/sleeping time;

        6. Incidence of eczema and duration;

        7. Infants growth
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stool Frequency</measure>
    <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
    <description>Average daily stool frequency during the measurement week</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Gastrointestinal Symptoms</measure>
    <time_frame>Weekly (Baseline to Day 84)</time_frame>
    <description>Number of participants with symptom of bloating and abdominal pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool Consistency</measure>
    <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
    <description>Average Bristol Score during the measurement week. The seven types of stool are:
= Separate hard lumps, like nuts (difficult to pass)
= Sausage-shaped but lumpy
= Like a sausage but with cracks in its surface
= Like a sausage or snake, smooth and soft
= Soft blobs with clear-cut edges (passed easily)
= Fluffy pieces with ragged edges; a mushy stool
= Watery, no solid pieces, entirely liquid Types 1 and 2 indicate constipation, with 3 and 4 being the ideal stools (especially the latter), as they are easy to defecate while not containing excess liquid, and 5, 6 and 7 tending towards diarrhoea.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Crying Time</measure>
    <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
    <description>Questionnaire recorded by parents. Average crying time per day during the measurement week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal Concentration of Short Chain Fatty Acid</measure>
    <time_frame>Baseline, Day 21</time_frame>
    <description>fecal concentration of acetate, propionate and butyrate acid</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Length</measure>
    <time_frame>Baseline, Day 28, Day 56, Day 84</time_frame>
    <description>Body length</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Eczema</measure>
    <time_frame>Throughout the study period (84 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal Laboratory Detection for sIgA</measure>
    <time_frame>Baseline, Day 84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal Bacterium Concentration</measure>
    <time_frame>Baseline, Day 21</time_frame>
    <description>bifidobacterium, lactobacillus, clostridium perfringens</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eczema Duration</measure>
    <time_frame>Throughout the study period (84 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Weight</measure>
    <time_frame>Baseline, Day 28, Day 56, Day 84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head Circumference</measure>
    <time_frame>Baseline, Day 28, Day 56, Day 84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chest Circumference</measure>
    <time_frame>Baseline, Day 28, Day 56, Day 84</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Milk Regurgitation Frequency</measure>
    <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
    <description>Questionnaire recorded by parents. Average daily frequency of milk regurgitation during the measurement week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Milk Feeding Quantity</measure>
    <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
    <description>Questionnaire recorded by parents. Average quantity of milk feeding per day during the measurement week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleeping Time</measure>
    <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
    <description>Questionnaire recorded by parents. Average sleeping time per day during the measurement week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI)</measure>
    <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
    <description>BMI is defined as the body mass divided by the square of the body height, and is universally expressed in units of kg/m^2 (kilogram per square meter).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Health Behavior</condition>
  <arm_group>
    <arm_group_label>Feihe New Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Feihe Stage 1 Formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral intake of Feihe stage 1 formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breast Feeding</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral intake of breast milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral intake of Feihe New Formula</intervention_name>
    <description>Oral intake of Feihe New Formula</description>
    <arm_group_label>Feihe New Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral intake of Feihe Stage 1 Formula</intervention_name>
    <description>Oral intake of Feihe Stage 1 Formula</description>
    <arm_group_label>Feihe Stage 1 Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Breast Feeding</intervention_name>
    <description>Oral intake of breast milk</description>
    <arm_group_label>Breast Feeding</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants aged 7-90 days;

          -  Fed by breast milk before enrollment;

          -  Parent or legal guardian fully understand the purpose and requirement, including the
             potential risks and side effects of the study;

          -  Willing to participate in the study and comply all the procedures;

          -  Concent form signed by parents.

        Exclusion Criteria:

          -  Twins, multiple birth, low birth weight children, over birth weight children or early
             birth children with gestational age less than 37 weeks;

          -  Think about the need to exclude C-section delivered infants? It's often the majority
             of births in Chinese tier-1 cities, so it will probably make the study recruitment
             slower, and postpone the study. The microflora of C-section infants in known to be
             different compared to normally born infants. At least, the mode of delivery should be
             noted and calculated into the primary and secondary outcome measurements as a
             potential confounding factor

          -  During pregnancy, the mothers had pregnancy complications or other disease that may
             affect the results;

          -  Having serious diseases that may affect study interventions, such as neonatal sepsis,
             pneumonia (associated with respiratory failure), heart failure and other disease;

          -  Having neonatal diarrhea or acute respiratory infections within 48hours before
             enrollment;

          -  Having potential metabolic diseases, chronic diseases, congenital malformations,
             central nervous system disorders, neuromuscular disorders or diseases affecting bone
             metabolism that may affect growth or the study results;

          -  Having taken any food containing prebiotics or probiotics tithing 15 days of
             enrollment;

          -  Having gluten allergy (celiac disease);

          -  Body weight-to-height Z-value&lt;-3 according to the standard of WHO;

          -  Receiving hormone therapy and intravenous nutrition;

          -  Lactose intolerance or allergic to ingredients of study product;

          -  Have participated in other clinical studies within 3 months prior to the date of
             screening;

          -  Unable to comply the study schedule.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jiancun Pan</last_name>
    <role>Study Director</role>
    <affiliation>Heilongjiang Feihe Dairy Co. Ltd.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sprim (Shanghai) Consulting Co., Ltd.</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200336</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2015</study_first_submitted>
  <study_first_submitted_qc>April 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2015</study_first_posted>
  <results_first_submitted>February 18, 2016</results_first_submitted>
  <results_first_submitted_qc>August 16, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 10, 2016</results_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Feihe New Formula</title>
          <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
        </group>
        <group group_id="P2">
          <title>Feihe Formula</title>
          <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
        </group>
        <group group_id="P3">
          <title>Breast Feeding</title>
          <description>Oral intake of breast milk
Oral intake: Oral intake</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
                <participants group_id="P3" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="59"/>
                <participants group_id="P3" count="58"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Feihe New Formula</title>
          <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
        </group>
        <group group_id="B2">
          <title>Feihe Formula</title>
          <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
        </group>
        <group group_id="B3">
          <title>Breast Feeding</title>
          <description>Oral intake of breast milk
Oral intake: Oral intake</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="59"/>
            <count group_id="B2" value="59"/>
            <count group_id="B3" value="58"/>
            <count group_id="B4" value="176"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.5" spread="18.3"/>
                    <measurement group_id="B2" value="58.4" spread="17.0"/>
                    <measurement group_id="B3" value="59.8" spread="20.5"/>
                    <measurement group_id="B4" value="57.9" spread="18.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="34"/>
                    <measurement group_id="B4" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="58"/>
                    <measurement group_id="B4" value="176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Stool Frequency</title>
        <description>Average daily stool frequency during the measurement week</description>
        <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Stool Frequency</title>
          <description>Average daily stool frequency during the measurement week</description>
          <units>Times per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="1.0"/>
                    <measurement group_id="O2" value="2.2" spread="0.9"/>
                    <measurement group_id="O3" value="2.3" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6" spread="0.5"/>
                    <measurement group_id="O2" value="1.8" spread="0.6"/>
                    <measurement group_id="O3" value="2.1" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.3"/>
                    <measurement group_id="O2" value="1.6" spread="0.5"/>
                    <measurement group_id="O3" value="1.5" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="0.3"/>
                    <measurement group_id="O2" value="1.5" spread="0.4"/>
                    <measurement group_id="O3" value="1.6" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Gastrointestinal Symptoms</title>
        <description>Number of participants with symptom of bloating and abdominal pain</description>
        <time_frame>Weekly (Baseline to Day 84)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Gastrointestinal Symptoms</title>
          <description>Number of participants with symptom of bloating and abdominal pain</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Stool Consistency</title>
        <description>Average Bristol Score during the measurement week. The seven types of stool are:
= Separate hard lumps, like nuts (difficult to pass)
= Sausage-shaped but lumpy
= Like a sausage but with cracks in its surface
= Like a sausage or snake, smooth and soft
= Soft blobs with clear-cut edges (passed easily)
= Fluffy pieces with ragged edges; a mushy stool
= Watery, no solid pieces, entirely liquid Types 1 and 2 indicate constipation, with 3 and 4 being the ideal stools (especially the latter), as they are easy to defecate while not containing excess liquid, and 5, 6 and 7 tending towards diarrhoea.</description>
        <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Stool Consistency</title>
          <description>Average Bristol Score during the measurement week. The seven types of stool are:
= Separate hard lumps, like nuts (difficult to pass)
= Sausage-shaped but lumpy
= Like a sausage but with cracks in its surface
= Like a sausage or snake, smooth and soft
= Soft blobs with clear-cut edges (passed easily)
= Fluffy pieces with ragged edges; a mushy stool
= Watery, no solid pieces, entirely liquid Types 1 and 2 indicate constipation, with 3 and 4 being the ideal stools (especially the latter), as they are easy to defecate while not containing excess liquid, and 5, 6 and 7 tending towards diarrhoea.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.61" spread="0.63"/>
                    <measurement group_id="O2" value="3.74" spread="0.55"/>
                    <measurement group_id="O3" value="3.76" spread="0.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.19" spread="0.63"/>
                    <measurement group_id="O2" value="3.59" spread="0.50"/>
                    <measurement group_id="O3" value="3.73" spread="0.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.09" spread="0.44"/>
                    <measurement group_id="O2" value="3.38" spread="0.38"/>
                    <measurement group_id="O3" value="3.50" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.05" spread="0.79"/>
                    <measurement group_id="O2" value="3.35" spread="0.46"/>
                    <measurement group_id="O3" value="3.57" spread="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Crying Time</title>
        <description>Questionnaire recorded by parents. Average crying time per day during the measurement week.</description>
        <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Crying Time</title>
          <description>Questionnaire recorded by parents. Average crying time per day during the measurement week.</description>
          <units>minutes/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.98" spread="2.88"/>
                    <measurement group_id="O2" value="2.90" spread="1.65"/>
                    <measurement group_id="O3" value="2.92" spread="2.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.43" spread="1.37"/>
                    <measurement group_id="O2" value="2.69" spread="0.97"/>
                    <measurement group_id="O3" value="2.62" spread="2.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.72" spread="0.77"/>
                    <measurement group_id="O2" value="2.40" spread="0.69"/>
                    <measurement group_id="O3" value="2.34" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.83" spread="0.79"/>
                    <measurement group_id="O2" value="2.06" spread="0.56"/>
                    <measurement group_id="O3" value="2.01" spread="0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fecal Concentration of Short Chain Fatty Acid</title>
        <description>fecal concentration of acetate, propionate and butyrate acid</description>
        <time_frame>Baseline, Day 21</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Fecal Concentration of Short Chain Fatty Acid</title>
          <description>fecal concentration of acetate, propionate and butyrate acid</description>
          <units>mg/g</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline acetate acid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.66" spread="1.31"/>
                    <measurement group_id="O2" value="4.75" spread="1.57"/>
                    <measurement group_id="O3" value="4.72" spread="1.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline propionate acid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.28" spread="0.51"/>
                    <measurement group_id="O2" value="1.27" spread="0.61"/>
                    <measurement group_id="O3" value="1.33" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline butyrate acid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.83" spread="0.51"/>
                    <measurement group_id="O2" value="0.85" spread="0.46"/>
                    <measurement group_id="O3" value="0.81" spread="0.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 21 acetate acid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.14" spread="1.10"/>
                    <measurement group_id="O2" value="4.77" spread="1.50"/>
                    <measurement group_id="O3" value="4.88" spread="1.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 21 propionate acid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.32" spread="0.52"/>
                    <measurement group_id="O2" value="1.35" spread="0.51"/>
                    <measurement group_id="O3" value="1.42" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 21 butyrate acid</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.84" spread="0.49"/>
                    <measurement group_id="O2" value="0.87" spread="0.47"/>
                    <measurement group_id="O3" value="0.86" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Length</title>
        <description>Body length</description>
        <time_frame>Baseline, Day 28, Day 56, Day 84</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Body Length</title>
          <description>Body length</description>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.9" spread="2.3"/>
                    <measurement group_id="O2" value="57.7" spread="2.4"/>
                    <measurement group_id="O3" value="57.8" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.3" spread="2.2"/>
                    <measurement group_id="O2" value="60.8" spread="2.2"/>
                    <measurement group_id="O3" value="61.1" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 56</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.6" spread="2.0"/>
                    <measurement group_id="O2" value="63.2" spread="2.3"/>
                    <measurement group_id="O3" value="63.5" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 84</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.6" spread="2.2"/>
                    <measurement group_id="O2" value="64.8" spread="2.4"/>
                    <measurement group_id="O3" value="65.4" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Eczema</title>
        <time_frame>Throughout the study period (84 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Eczema</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fecal Laboratory Detection for sIgA</title>
        <time_frame>Baseline, Day 84</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Fecal Laboratory Detection for sIgA</title>
          <units>ug/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.8" spread="19.5"/>
                    <measurement group_id="O2" value="53.0" spread="20.7"/>
                    <measurement group_id="O3" value="55.5" spread="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 84</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.3" spread="12.9"/>
                    <measurement group_id="O2" value="62.7" spread="11.8"/>
                    <measurement group_id="O3" value="65.9" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fecal Bacterium Concentration</title>
        <description>bifidobacterium, lactobacillus, clostridium perfringens</description>
        <time_frame>Baseline, Day 21</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Fecal Bacterium Concentration</title>
          <description>bifidobacterium, lactobacillus, clostridium perfringens</description>
          <units>log (colony forming units)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline bifidobacterium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.56" spread="0.76"/>
                    <measurement group_id="O2" value="7.55" spread="0.71"/>
                    <measurement group_id="O3" value="7.58" spread="0.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline lactobacillus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.61" spread="0.86"/>
                    <measurement group_id="O2" value="6.58" spread="0.83"/>
                    <measurement group_id="O3" value="6.63" spread="0.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline clostridium perfringens</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.69" spread="1.28"/>
                    <measurement group_id="O2" value="4.73" spread="1.20"/>
                    <measurement group_id="O3" value="4.64" spread="1.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 21 bifidobacterium</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.51" spread="0.55"/>
                    <measurement group_id="O2" value="7.67" spread="0.53"/>
                    <measurement group_id="O3" value="7.71" spread="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 21 lactobacillus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.65" spread="0.95"/>
                    <measurement group_id="O2" value="6.78" spread="0.98"/>
                    <measurement group_id="O3" value="6.80" spread="0.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 21 clostridium perfringens</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.73" spread="1.26"/>
                    <measurement group_id="O2" value="4.57" spread="1.41"/>
                    <measurement group_id="O3" value="4.51" spread="1.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Eczema Duration</title>
        <time_frame>Throughout the study period (84 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Eczema Duration</title>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.1" spread="15.0"/>
                    <measurement group_id="O2" value="45.2" spread="21.1"/>
                    <measurement group_id="O3" value="38.6" spread="17.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Weight</title>
        <time_frame>Baseline, Day 28, Day 56, Day 84</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Body Weight</title>
          <units>g</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5191.5" spread="715.2"/>
                    <measurement group_id="O2" value="5291.5" spread="738.9"/>
                    <measurement group_id="O3" value="5462.1" spread="1040.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6142.4" spread="678.3"/>
                    <measurement group_id="O2" value="6251.7" spread="747.5"/>
                    <measurement group_id="O3" value="6370.7" spread="912.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 56</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6922.9" spread="701.5"/>
                    <measurement group_id="O2" value="6975.4" spread="712.9"/>
                    <measurement group_id="O3" value="7102.6" spread="842.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 84</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7430.5" spread="650.0"/>
                    <measurement group_id="O2" value="7484.1" spread="699.1"/>
                    <measurement group_id="O3" value="7575.0" spread="775.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Head Circumference</title>
        <time_frame>Baseline, Day 28, Day 56, Day 84</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Head Circumference</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.5" spread="1.2"/>
                    <measurement group_id="O2" value="38.7" spread="1.2"/>
                    <measurement group_id="O3" value="39.0" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.9" spread="1.1"/>
                    <measurement group_id="O2" value="40.1" spread="1.1"/>
                    <measurement group_id="O3" value="40.4" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 56</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.1" spread="1.0"/>
                    <measurement group_id="O2" value="41.4" spread="1.1"/>
                    <measurement group_id="O3" value="41.5" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 84</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.1" spread="1.0"/>
                    <measurement group_id="O2" value="42.4" spread="1.0"/>
                    <measurement group_id="O3" value="42.4" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chest Circumference</title>
        <time_frame>Baseline, Day 28, Day 56, Day 84</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Chest Circumference</title>
          <units>cm</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.9" spread="1.2"/>
                    <measurement group_id="O2" value="37.2" spread="1.1"/>
                    <measurement group_id="O3" value="37.3" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 28</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.2" spread="1.1"/>
                    <measurement group_id="O2" value="38.6" spread="1.2"/>
                    <measurement group_id="O3" value="38.7" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 56</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.4" spread="1.0"/>
                    <measurement group_id="O2" value="39.6" spread="1.1"/>
                    <measurement group_id="O3" value="39.8" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 84</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.5" spread="1.0"/>
                    <measurement group_id="O2" value="40.6" spread="1.0"/>
                    <measurement group_id="O3" value="40.9" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Milk Regurgitation Frequency</title>
        <description>Questionnaire recorded by parents. Average daily frequency of milk regurgitation during the measurement week.</description>
        <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Milk Regurgitation Frequency</title>
          <description>Questionnaire recorded by parents. Average daily frequency of milk regurgitation during the measurement week.</description>
          <units>Times/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.68" spread="1.60"/>
                    <measurement group_id="O2" value="2.47" spread="1.42"/>
                    <measurement group_id="O3" value="2.43" spread="1.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.70" spread="1.27"/>
                    <measurement group_id="O2" value="2.02" spread="0.89"/>
                    <measurement group_id="O3" value="1.89" spread="1.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.75" spread="1.21"/>
                    <measurement group_id="O2" value="1.25" spread="0.61"/>
                    <measurement group_id="O3" value="1.17" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.05" spread="0.79"/>
                    <measurement group_id="O2" value="0.71" spread="0.40"/>
                    <measurement group_id="O3" value="0.64" spread="0.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Milk Feeding Quantity</title>
        <description>Questionnaire recorded by parents. Average quantity of milk feeding per day during the measurement week.</description>
        <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Milk Feeding Quantity</title>
          <description>Questionnaire recorded by parents. Average quantity of milk feeding per day during the measurement week.</description>
          <units>ml/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="732.1" spread="169.3"/>
                    <measurement group_id="O2" value="742.2" spread="97.6"/>
                    <measurement group_id="O3" value="750.7" spread="119.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="928.6" spread="104.6"/>
                    <measurement group_id="O2" value="936.3" spread="88.3"/>
                    <measurement group_id="O3" value="946.0" spread="98.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1063.3" spread="107.1"/>
                    <measurement group_id="O2" value="1062.0" spread="98.1"/>
                    <measurement group_id="O3" value="1070.2" spread="83.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1179.0" spread="101.5"/>
                    <measurement group_id="O2" value="1181.8" spread="95.0"/>
                    <measurement group_id="O3" value="1182.9" spread="69.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sleeping Time</title>
        <description>Questionnaire recorded by parents. Average sleeping time per day during the measurement week.</description>
        <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
          </group>
          <group group_id="O2">
            <title>Feihe Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Oral intake: Oral intake</description>
          </group>
        </group_list>
        <measure>
          <title>Sleeping Time</title>
          <description>Questionnaire recorded by parents. Average sleeping time per day during the measurement week.</description>
          <units>hours/day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.0" spread="0.8"/>
                    <measurement group_id="O2" value="17.8" spread="0.6"/>
                    <measurement group_id="O3" value="17.9" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.6" spread="0.8"/>
                    <measurement group_id="O2" value="17.4" spread="0.5"/>
                    <measurement group_id="O3" value="17.6" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.9" spread="0.5"/>
                    <measurement group_id="O2" value="16.8" spread="0.5"/>
                    <measurement group_id="O3" value="16.9" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.4" spread="0.6"/>
                    <measurement group_id="O2" value="16.4" spread="0.5"/>
                    <measurement group_id="O3" value="16.5" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Mass Index (BMI)</title>
        <description>BMI is defined as the body mass divided by the square of the body height, and is universally expressed in units of kg/m^2 (kilogram per square meter).</description>
        <time_frame>Baseline, Week 4, Week 8, Week 12</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Feihe New Formula</title>
            <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake of Feihe New Formula: Oral intake of Feihe New Formula</description>
          </group>
          <group group_id="O2">
            <title>Feihe Stage 1 Formula</title>
            <description>Oral intake of Feihe stage 1 formula
Oral intake of Feihe Stage 1 Formula: Oral intake of Feihe Stage 1 Formula</description>
          </group>
          <group group_id="O3">
            <title>Breast Feeding</title>
            <description>Oral intake of breast milk
Breast Feeding: Oral intake of breast milk</description>
          </group>
        </group_list>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <description>BMI is defined as the body mass divided by the square of the body height, and is universally expressed in units of kg/m^2 (kilogram per square meter).</description>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.9" spread="1.3"/>
                    <measurement group_id="O2" value="15.8" spread="1.4"/>
                    <measurement group_id="O3" value="16.2" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.9" spread="1.1"/>
                    <measurement group_id="O2" value="16.9" spread="1.3"/>
                    <measurement group_id="O3" value="17.0" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.6" spread="1.3"/>
                    <measurement group_id="O2" value="17.5" spread="1.2"/>
                    <measurement group_id="O3" value="17.6" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 12</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.8" spread="1.3"/>
                    <measurement group_id="O2" value="17.8" spread="1.1"/>
                    <measurement group_id="O3" value="17.7" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Feihe New Formula</title>
          <description>Oral intake of Feihe new formula with hydrolyzed protein supplied by Arla Foods Ingredients.
Oral intake: Oral intake</description>
        </group>
        <group group_id="E2">
          <title>Feihe Formula</title>
          <description>Oral intake of Feihe stage 1 formula
Oral intake: Oral intake</description>
        </group>
        <group group_id="E3">
          <title>Breast Feeding</title>
          <description>Oral intake of breast milk
Oral intake: Oral intake</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Charlie Zhang</name_or_title>
      <organization>Sprim (Shanghai) Consulting Co., Ltd.</organization>
      <phone>+86 (21) 51097272</phone>
      <email>charlie.zhang@sprim.cn</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

